4D Molecular Therapeutics (FDMT)
(Real Time Quote from BATS)
$23.15 USD
-0.38 (-1.62%)
Updated Apr 26, 2024 11:36 AM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: -- |
3/2024 | $-0.73 | -8.22% |
Earnings Summary
For their last quarter, 4D Molecular Therapeutics (FDMT) reported earnings of -$0.77 per share, missing the Zacks Consensus Estimate of -$0.68 per share. This reflects a negative earnings surprise of 13.24%. Look out for FDMT's next earnings release expected on May 08, 2024. For the next earning release, we expect the company to report earnings of -$0.73 per share, reflecting a year-over-year increase of 17.05%.
Earnings History
Price & Consensus
Zacks News for FDMT
Strength Seen in Lyra Therapeutics, Inc. (LYRA): Can Its 6.9% Jump Turn into More Strength?
FDMT: What are Zacks experts saying now?
Zacks Private Portfolio Services